Evidence supporting the use of: Apocynin
For the health condition: Strokes
Synopsis
Source of validity: Scientific
Rating (out of 5): 2
Apocynin is a natural compound derived from the root of Picrorhiza kurroa and has been studied for its ability to inhibit the enzyme NADPH oxidase, which produces reactive oxygen species (ROS). Excessive ROS production is implicated in the pathogenesis of ischemic stroke and neuronal injury due to oxidative stress. Preclinical studies in animal models of stroke have shown that apocynin can reduce infarct size, protect neurons, and improve neurological outcomes by attenuating oxidative damage and inflammation. For example, research in rodent models demonstrates that apocynin administration before or after induced cerebral ischemia can reduce markers of oxidative stress and improve recovery.
However, despite promising results in laboratory and animal studies, there is currently a lack of robust clinical trials in humans to confirm these benefits. No approved stroke therapies include apocynin, and its efficacy and safety in human stroke patients remain unproven. As such, while there is a scientific rationale and some preclinical evidence supporting the potential of apocynin in stroke management, the evidence is still preliminary and does not justify its use in standard clinical practice for stroke at this time.
Other ingredients used for Strokes
acetyl l-carnitinealgal oil
anthocyanins
citicoline
DHA (docosahexaeonic acid)
EPA (eicosapentaenoic acid)
fisetin
ginkgo biloba
nattokinase
omega-3 fatty acids
resveratrol
tocotrienols
vinpocetine
swertia
7,8-Dihydroxyflavone
Alpha-Lipoic Acid
Acetylsalicylic acid
Apocynin
Butylphthalide
bacoside
Crocetin
Danshen
Eicosapentaenoic Acid